science

Sipavibart

Sipavibart is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Sipavibart rather than just read about it. In short: Sipavibart, sold under the brand name Kavigale, is a medication used for the prevention of COVID-19 in people who are immunocompromised. Sipavibart is a recombinant human IgG1 monoclonal antibody that provides passive immunization against SARS-CoV-2 by binding its spike protein receptor binding domain.

Key takeaways

Sipavibart belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Sipavibart to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Sipavibart from memory before moving on to harder problems.

Reference excerpt

Sipavibart, sold under the brand name Kavigale, is a medication used for the prevention of COVID-19 in people who are immunocompromised. Sipavibart is a recombinant human IgG1 monoclonal antibody that provides passive immunization against SARS-CoV-2 by binding its spike protein receptor binding domain. Sipavibart was authorized for medical use in the European Union in January 2025.

Medical uses Sipavibart is indicated for the pre-exposure prophylaxis of COVID-19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) and who are immunocompromised due to a medical condition or receipt of immunosuppressive treatments.

Society and culture

Legal status In December 2024, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Kavigale, intended for the prevention of COVID-19 in immunocompromised people aged twelve years of age and older. Kavigale was reviewed under the EMA's accelerated assessment program. The applicant for this medicinal product is AstraZeneca AB. Sipavibart was authorized for medical use in the European Union in January 2025.

Names Sipavibart is the international nonproprietary name. Sipavibart is sold under the brand name Kavigale.

References

Further reading Loubet P, Gaborit B, Salpin M, Gardeney H, Benotmane I, Systchenko T (December 2024). "Characteristics of the first immunocompromised patients to receive sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France". Human Vaccines & Immunotherapeutics. 20 (1) 2387221. doi:10.1080/21645515.2024.2387221. PMC 11328879. PMID 39143811. Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, et al. (2024). "Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies". Pathogens & Immunity. 10 (1): 1–11. doi:10.20411/pai.v10i1.752. PMC 11464000. PMID 39391808.

Worked examples

Example 1 — a first encounter with Sipavibart

Start with the simplest possible case. Write down what Sipavibart claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Sipavibart before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Sipavibart ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Sipavibart

In research: Sipavibart appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Sipavibart in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Sipavibart is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antiviral drugs, Anti–RNA virus drugs, COVID-19 drug development, so understanding it makes those chapters shorter.
In everyday life: Look for Sipavibart outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Sipavibart” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Sipavibart in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Sipavibart means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Sipavibart out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Sipavibart in simple terms?

Why does Sipavibart matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Sipavibart?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Sipavibart.